✓ Betaling met creditcard hersteld — veilige afrekening via Privacy Shield

Pantocid Injectie

✅ Rapid acid relief
✅ Gastric ulcer healing
✅ Reduces acid reflux
✅ Prevents acid-related damage
✅ Effective GERD treatment

Pantocid Injection contains Pantoprazole.

Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring  · Laatst beoordeeld: mei 2026

Meer kopen, meer besparen Prijs per flesje
1 Vial/s
US$6.00/vial
US$6,00
2 Vial/s
US$5.75/vial · bespaar 4%
US$11.50
3 Vial/s
US$5.50/vial · bespaar 8%
US$16,50
6 Vial/s BESTE WAARDE
US$4.50/vial · bespaar 25%
US$27.00
Versleutelde checkout
Crypto betaalt 10% minder
Discrete wereldwijde levering
1.400+ klanten · 50+ landen

⚡ Quick Answer — What is Pantocid Injection?

Pantocid Injectie is pantoprazole sodium 40 mg per vial for intravenous use, made by Sun Pharma from a WHO-GMP certified manufacturing facility. This is the parenteral form of pantoprazole used in hospital when a patient cannot take oral PPI — nil-by-mouth, post-operative, intubated, or with active upper-GI bleeding. Standaard dosering: 40 mg IV once daily reconstituted in 0.9% saline, infused over 15 minutes. For active non-variceal upper-GI bleed with a high-risk endoscopic lesion (Forrest Ia/Ib/IIa/IIb), the protocol is an 80 mg IV bolus followed by an 8 mg/h continuous infusion for 72 hours. Switch to oral pantoprazole (e.g. Pantodac 40 mg) as soon as the patient can swallow safely. Continued IV PPI beyond 3–5 days adds nothing pharmacologically.

Wat u krijgt bij MedsBase: WHO-GMP gecertificeerde fabrikant · Discrete verpakking · Wereldwijde verzending · 1.400+ geverifieerde klantbeoordelingen

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

Hospital-use medication. Pantocid Injection is a parenteral medication intended for inpatient or supervised clinical use. It is supplied as a sterile lyophilised powder vial that must be reconstituted with 0.9% sodium chloride and administered intravenously by a qualified healthcare professional. Self-administration of this product is not appropriate. If you can take an oral PPI, oral pantoprazole (Pantodac, Pan, Pentab, Walapan-40) or any other oral PPI gives equivalent acid suppression at a fraction of the cost.

What Pantocid Injection Is

Pantocid Injection is the Sun Pharma brand of intravenous pantoprazole sodium. Each vial contains pantoprazole sodium equivalent to 40 mg of pantoprazole base, supplied as a sterile lyophilised powder for reconstitution. It is the parenteral form of the same molecule available orally as Pantodac, Pan, Pentab, Penlip, and Walapan-40.

How Pantocid Injection Works

Pantoprazole is a benzimidazole proton-pump inhibitor. After IV administration, the drug is concentrated in the acidic secretory canaliculi of the stomach’s parietal cells. There it is protonated to the active sulphenamide form, which forms a covalent disulphide bond with cysteine residues on the H+/K+-ATPase pump. This irreversibly blocks acid secretion until new pumps are synthesised, giving 24–72 hours of pharmacodynamic effect from each dose despite the drug’s short ~1-hour plasma half-life. Continuous infusion is used for active GI bleeding because it maintains an elevated intragastric pH at > 6 — the threshold above which platelet aggregation is preserved and clot stability is improved.

Indications — When IV Pantoprazole Is Used

1. Active upper-GI bleeding from a peptic ulcer (post-endoscopy)

The largest evidence base. After endoscopic haemostasis of a high-risk lesion (active arterial bleeding Forrest Ia, oozing Ib, non-bleeding visible vessel IIa, or adherent clot IIb), a 72-hour IV PPI infusion at 80 mg bolus + 8 mg/h reduces rebleeding, surgery, and 30-day mortality. Patients with low-risk lesions (Forrest IIc/III) do not need IV therapy and can go straight to oral high-dose pantoprazole.

2. Patients NPO (nil by mouth) needing acid suppression

Post-operative ileus, mechanical ventilation, severe pancreatitis, persistent vomiting, or dysphagia. Once enteral nutrition resumes, switch to oral pantoprazole.

3. ICU stress-ulcer prophylaxis

For mechanically ventilated patients > 48 hours, those with coagulopathy, or those on vasopressors. Note: prolonged ICU PPI use is associated with increased C. difficile infection and ventilator-associated pneumonia — review the indication daily and stop when no longer needed.

4. Zollinger-Ellison syndrome — bridging

For patients with acid hypersecretory states who cannot take oral PPI temporarily.

Dosing and Administration

IndicatieDoseringOpmerkingen
Standaard dosis voor volwassenen40 mg IV once dailyReconstitute with 10 mL 0.9% sodium chloride; may further dilute in 100 mL 0.9% NaCl; infuse over 15 minutes
Upper-GI bleed (high-risk lesion, post-endoscopy)80 mg IV bolus, then 8 mg/h continuous infusion72 hours, then step down to oral 40 mg twice daily for 14 days
Severe Zollinger-Ellison80 mg IV every 8–12 hours (specialist-led)0.9% NaCl reconstitution; specialist supervision
LeverfunctiestoornisMaximum 40 mg/dayMonitor LFTs
NierfunctiestoornisNo dose adjustment neededStandaardregime

Compatibility: Reconstitute only with 0.9% sodium chloride. Do not mix with other IV medications in the same line. The reconstituted solution is stable for 12 hours at room temperature; discard any unused portion.

Switch to oral PPI as soon as the patient can swallow safely. Continued IV PPI beyond 3–5 days has no pharmacological advantage over oral therapy and adds substantially to cost and infection risk.

Bijwerkingen

Vaak (1–10%): headache, diarrhoea, nausea, abdominal pain, injection-site reactions (pain, thrombophlebitis at the cannula site).

Zeldzaam maar belangrijk: hypersensitivity (rash, angioedema; very rarely anaphylaxis), acute interstitial nephritis, hepatotoxicity (rare), severe hypomagnesaemia (with prolonged use), C. difficile infection (especially in hospitalised patients), and ventilator-associated pneumonia.

Contra-indicaties

  • Known hypersensitivity to pantoprazole or any benzimidazole PPI
  • Concurrent rilpivirine (HIV) — absolute contraindication
  • Ernstige leverfunctiestoornis — dosis verlagen

Opslag

Store unopened vials at 15–30 °C, protected from light. After reconstitution, the solution is stable for 12 hours at room temperature; refrigeration is not required but does not extend stability beyond 24 hours. Discard any visibly discoloured or particulate-containing solution.

Veelgestelde vragen

When is IV pantoprazole used instead of oral?

Only when a patient cannot take oral PPI — nil-by-mouth, post-operative, intubated, persistent vomiting, severe dysphagia — or in the specific context of acute upper-GI bleeding where high-dose continuous infusion improves outcomes after endoscopic haemostasis. Once enteral nutrition resumes, oral pantoprazole gives equivalent acid suppression at a fraction of the cost.

Why is the bleeding-protocol dose so much higher (80 mg + 8 mg/h)?

Active upper-GI bleeding requires sustained intragastric pH > 6 to stabilise platelet aggregation and protect the clot from peptic digestion. The 80 mg loading dose plus 8 mg/h continuous infusion is the regimen with the largest randomised-trial evidence base for this. Lower or intermittent dosing produces large pH fluctuations and less rebleeding protection.

How long should IV PPI be continued?

For acute GI bleed, 72 hours of continuous infusion, then step down to oral 40 mg twice daily for 14 days, then once daily. For NPO patients, switch to oral PPI as soon as the gut works. Prolonged IV PPI > 5 days has no pharmacological advantage and increases C. difficile and pneumonia risk in hospital.

Is IV pantoprazole better than IV omeprazole or esomeprazole?

For acid suppression alone, no — all IV PPIs reach equivalent intragastric pH. Pantoprazole is preferred in clinical practice because of its cleaner drug-interaction profile (especially relevant in ICU patients on multiple drugs metabolised by CYP3A4 and CYP2C19) and because the bleeding-protocol evidence base is largest with pantoprazole and esomeprazole.

Can it be mixed with other IV drugs?

No. Reconstitute pantoprazole only with 0.9% sodium chloride and administer through a dedicated IV line. Do not co-administer with other medications in the same line because of compatibility issues with several common IV drugs.

Is IV pantoprazole safe in pregnancy?

Pantoprazole has reasonable pregnancy safety data. IV pantoprazole would be used in pregnancy only when oral therapy is impossible — e.g. hyperemesis gravidarum severe enough to need parenteral nutrition, or acute peptic ulcer bleeding. Discuss with obstetric and GI teams.

What are the side effects of IV pantoprazole?

Most are similar to oral PPI: headache, diarrhoea, nausea. Specific to IV use: injection-site pain or thrombophlebitis at the cannula. Important hospital complications to monitor for: C. difficile infection, ventilator-associated pneumonia, hypomagnesaemia (long ICU stays), and rare acute interstitial nephritis (creatinine rise).

Does IV pantoprazole interact with clopidogrel?

Pantoprazole has the smallest clopidogrel interaction of any PPI because it does not inhibit CYP2C19 to a clinically significant degree. This is one reason it is the default IV PPI in cardiology and cardiac-surgery wards.

Can it be given by a peripheral cannula?

Yes — standard 40 mg dose reconstituted and diluted in 100 mL 0.9% saline can be given through a peripheral line. The 8 mg/h continuous infusion for GI bleed is more often given through a dedicated line because of the duration. Watch for thrombophlebitis at the cannula site.

How is it stored after reconstitution?

The reconstituted and diluted solution is stable for 12 hours at room temperature in 0.9% saline. Refrigeration extends shelf life to 24 hours. Discard any solution that is discoloured, hazy, or contains particulate matter.

Medische disclaimer: Deze informatie is voor volwassenen onder medisch toezicht. Maagzuurgerelateerde aandoeningen kunnen ernstige onderliggende oorzaken hebben, waaronder maagzweren, Barrett-slokdarm en maagkanker — aanhoudende of alarmerende symptomen (gewichtsverlies, dysfagie, bloedbraken, melaena, bloedarmoede, leeftijd > 55 met nieuw ontstane symptomen) vereisen onderzoek. Bespreek elk maagzuurremmend medicijn, doseringswijziging of geplande stopzetting met een gekwalificeerde arts. Langdurige maagzuurremming is niet onschadelijk — evalueer de noodzaak minstens jaarlijks met uw voorschrijver.

Gerelateerde alternatieven

Andere producten in Algemene gezondheid die klanten ook bekijken:

Meer opties in de behandeling van maagzuurreflux

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Sterkte

40 mg

Hoeveelheid

1 Vial/s, 2 Vial/s, 3 Vial/s, 6 Vial/s

Beoordelingen

Er zijn nog geen beoordelingen

Plaats een beoordeling
Pantocid Injection Pantocid Injectie
Beoordeling*
0/5
* Beoordeling is verplicht
* Antwoord is verplicht
Jouw beoordeling
* Beoordeling is verplicht
Naam
* Naam is verplicht
Voeg foto's of video toe aan je beoordeling

Vragen & antwoorden

Stel een vraag
Pantocid Injection Pantocid Injectie
Uw vraag
* Vraag is verplicht
Naam
* Naam is verplicht
Er zijn nog geen vragen